Melavisk® (Viscoprotector) Instructions for Use
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
| Melavisk® | Viscoprotector: syringes 1 ml or 2 ml 1 or 2 pcs. |
Dosage Form, Packaging, and Composition
Viscoprotector in the form of a transparent, viscous solution.
| 1 ml | |
| Sodium hyaluronate | 19.4 mg (1.6%) |
| Sodium chloride | 6.5 mg |
| Hydroxypropylmethylcellulose | 0.6 mg |
| Dynamic viscosity more than 2000 mPa·s (at a temperature of 25°C (77°F) and a shear rate of 1 s-1) Osmolality 300±40 mOsm/kg PH 6.8-7.6 |
Excipients: anhydrous disodium phosphate – 2 mg, sodium dihydrogen phosphate monohydrate – 0.45 mg, water for injections – up to 1 ml.
1 ml – glass syringes (1) – packs or blister packs (1) – cardboard packs×.
1 ml – glass syringes (1) – packs or blister packs (1) in a set with 1 or 2 cannulas* – cardboard packs×.
1 ml – glass syringes (1) – packs or blister packs (2) – cardboard packs×.
1 ml – glass syringes (1) – packs or blister packs (2) in a set with 2 or 4 cannulas* – cardboard packs×.
1 ml – glass syringes (1) – packs or blister packs (5) – cardboard packs×.
1 ml – glass syringes (1) – packs or blister packs (5) in a set with 5 or 10 cannulas* – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (1) – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (1) in a set with 1 or 2 cannulas* – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (2) – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (2) in a set with 2 or 4 cannulas* – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (5) – cardboard packs×.
2 ml – glass syringes (1) – packs or blister packs (5) in a set with 5 or 10 cannulas* – cardboard packs×.
× with or without first opening control.
* The set may include a sterile ophthalmic surgical cannula 23G×7/8'' or 25G×7/8'', or 27G×7/8'' (FSZ 2012/12331 dated 13.04.2020; FSZ 2011/08973 dated 16.09.2019).
It is allowed to include 3, 6, or 15 tracking labels in the cardboard pack.
Therapeutic Category
Medical device for use in ophthalmic surgery
Properties
Viscoprotector.
Due to its viscoelastic properties, transparency, and ability to protect corneal endothelial cells, this agent provides a view of the anterior chamber of the eye, minimizes the risk of mechanical damage to any of the involved eye structures, and preserves tissue integrity during surgical manipulations.
It maintains the volume of the deep chamber during surgery on the anterior segment of the eye, thereby increasing the effectiveness of the procedure and reducing its traumatic impact on the corneal endothelium and other eye tissues.
Sodium hyaluronate is obtained by fermentation of Streptococcus equi bacteria and is thoroughly purified.
Scope of Application
For use in ophthalmology during surgical interventions on the anterior segment of the eye: cataract removal; intraocular lens implantation.
ICD codes
| ICD-10 code | Indication |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The solution is for individual and single use only.
Procedures with this medical device require special training and special skills and are intended for use in medical institutions.
Side Effects
A review of clinical studies of similar devices showed that in some cases, a short-term increase in intraocular pressure was noted in the postoperative period.
In rare cases, as a result of the use of viscoelastics, postoperative inflammatory reactions (iritis, hypopyon), as well as corneal edema and decompensation, were observed.
The relationship of these conditions with the use of the devices has not been established.
Contraindications
Individual hypersensitivity to the components of the composition.
Use During Pregnancy and Breastfeeding
There are no data on the safety of use during pregnancy and breastfeeding.
Special Instructions
This is not a medicinal product.
Drug Interactions
Sodium hyaluronate is incompatible with quaternary ammonium compounds (benzalkonium chloride solutions), so contact of the device with these substances or with medical surgical instruments treated with these solutions should be avoided.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer